SCHEMBL24358193

SCHEMBL24358193

CCOc1cnc(-c2csc(N)n2)c(C)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 5/20 0.46
KMT2A Q03164 5/20 0.46
L3MBTL1 Q9Y468 2/20 0.44
ALDH1A1 P00352 7/20 0.40
HSD17B10 Q99714 2/20 0.40
TP53 P04637 1/20 0.40
CYP3A4 P08684 1/20 0.40
TSHR P16473 1/20 0.40
MAPT P10636 6/20 0.39
HTT P42858 3/20 0.39
KDM4E B2RXH2 2/20 0.39
PKM P14618 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
NPC1 O15118 5/20 0.38
RAB9A P51151 3/20 0.38
SMN1; SMN2 Q16637 5/20 0.38
POLB P06746 1/20 0.38
RECQL P46063 2/20 0.37
THRB P10828 1/20 0.37
GFER P55789 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2381338 0.81 MEN1 (0.49) MEN1KMT2AL3MBTL1ALDH1A1HSD17B10
SCHEMBL24358021 0.75 MEN1 (0.52) MEN1KMT2AALDH1A1HSD17B10TP53
SCHEMBL29601739 0.75 MEN1 (0.52) MEN1KMT2AALDH1A1HSD17B10TP53
SCHEMBL30745730 0.74 NPC1 (0.57) MEN1KMT2AALDH1A1HSD17B10MAPT
SCHEMBL27039641 0.74 MEN1 (0.55) MEN1KMT2AALDH1A1TP53MAPT
SCHEMBL24358194 0.74 NPC1 (0.57) MEN1KMT2AALDH1A1HSD17B10MAPT
SCHEMBL30745797 0.74 MEN1 (0.55) MEN1KMT2AALDH1A1TP53MAPT
SCHEMBL24358034 0.72 MEN1 (0.41) MEN1KMT2AL3MBTL1ALDH1A1HSD17B10
SCHEMBL7403707 0.71 RAB9A (0.68) MEN1KMT2AALDH1A1HSD17B10TP53
SCHEMBL27916462 0.70 MAPT (0.45) MEN1KMT2AL3MBTL1ALDH1A1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022087326-A1 HETEROCYCLIC COMPOUNDS AND THEIR USE FOR TREATMENT OF HELMINTHIC INFECTIONS AND DISEASES CELGENE CORPORATION (US) 2022-04-28 WO disclosed